About Index Trending news
Seattle Genetics

Seattle Genetics

Work at Seattle Genetics? Add yourself to this profile

Seattle Genetics

Biotechnology company focused on innovative monoclonal antibody-based therapies for the treatment of cancer. View our Twitter guidelines our site


Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity

Unknown size

GeekWire , Xconomy

Seattle Genetics cancer drug clinical trials will go forward after FDA lifts hold


Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights


Shares of Seattle Genetics tumble after FDA places clinical hold on leukemia drug following patient deaths


Seattle Genetics announces successful clinical trial of lymphoma treatment

The Motley Fool

Seattle Genetics Has Been Heating Up: Time to Buy?

The Motley Fool

Taking Inventory on Seattle Genetics, Inc. Earnings

Earnings Health Stock markets
The Motley Fool

Why Seattle Genetics, Inc. Stock Rose 10% in March

The Motley Fool

Seattle Genetics, Inc. Grows Sales, Waits for Data

Health Earnings

Despite record sales of cancer drug, Seattle Genetics shares fall 7 percent

Earnings Health